References
- Takemura K, Komeda M, Yagi M, Himeno C, Izumikawa M, Doi T, Direct inner ear infusion of dexamethasone attenuates noise-induced trauma in guinea pig. Hear Res 2004;196:58–68.
- Wei BPC, Mubiru S, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2006:CD003998.
- Eshraghi AA, Adil E, He J, Graves R, Balkany TJ, van de Water TR. Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma-induced hearing loss. Otol Neurotol 2007;28:842–9.
- Braun S, Ye Q, Radeloff A, Kiefer J, Gstoettner W, Tillein J. Protection of inner ear function after cochlear implantation: compound action potential measurements after local application of glucocorticoids in the guinea pig cochlea. ORL J Otorhinolaryngol Relat Spec 2011;73:219–28.
- Kiefer J, Gstoettner W, Baumgartner W, Pok SM, Tillein J, Ye Q, Conservation of low-frequency hearing in cochlear implantation. Acta Otolaryngol 2004;124:272–80.
- James DP, Eastwood H, Richardson RT, O'Leary SJ. Effects of round window dexamethasone on residual hearing in a guinea pig model of cochlear implantation. Audiol Neurootol 2008;13:86–96.
- Eastwood H, Chang A, Kel G, Sly D, Richardson R, O'Leary SJ. Round window delivery of dexamethasone ameliorates local and remote hearing loss produced by cochlear implantation into the second turn of the guinea pig cochlea. Hear Res 2010;265:25–9.
- Salt AN, Plontke SK. Principles of local drug delivery to the inner ear. Audiol Neurootol 2009;14:350–60.
- Arnold W, Senn P, Hennig M, Michaelis C, Deingruber K, Scheler R, Novel slow- and fast-type drug release round-window microimplants for local drug application to the cochlea: an experimental study in guinea pigs. Audiol Neurootol 2005;10:53–63.
- Lefebvre PP, Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol 2002;122:698–702.
- Jolly C, Garnham C, Mirzadeh H, Truy E, Martini A, Kiefer J, Electrode features for hearing preservation and drug delivery strategies. Adv Otorhinolaryngol 2010;67:28–42.
- Hochmair I, Nopp P, Jolly C, Schmidt M, Schosser H, Garnham C, MED-EL cochlear implants: state of the art and a glimpse into the future. Trends Amplif 2006;10:201–19.
- Public health web notification: risk of bacterial meningitis in children with cochlear implants. US Food and Drug Administration. 2002.
- Cohen NL, Hirsch BE. Current status of bacterial meningitis after cochlear implantation. Otol Neurotol 2010;31:1325–8.
- Reefhuis J, Honein MA, Whitney CG, Chamany S, Mann EA, Biernath KR, Risk of bacterial meningitis in children with cochlear implants. N Engl J Med 2003;349:435–45.
- Niedermeier K, Braun S, Fauser C, Straubinger R, Stark T. Pneumococcal meningitis post cochlear implantation: development of an animal model in the guinea pig. Hear Res 2012;289:108–15.
- Wei BPC, Shepherd RK, Robins-Browne RM, Clark GM, O'Leary SJ. Pneumococcal meningitis post-cochlear implantation: potential routes of infection and pathophysiology. Otolaryngol Head Neck Surg 2010;143(5 Suppl 3):S15–23.
- Roland PS, Wright CG, Isaacson B. Cochlear implant electrode insertion: the round window revisited. Laryngoscope 2007;117:1397–402.
- Stark T, Niedermeyer HP, Knopf A, Sudhoff H. Surgical technique for implantation of the MED-EL SONATATI. ORL J Otorhinolaryngol Relat Spec 2011;73:196–200.
- Wei BPC, Shepherd RK, Robins-Browne RM, Clark GM, O'Leary SJ. Threshold shift: effects of cochlear implantation on the risk of pneumococcal meningitis. Otolaryngol Head Neck Surg 2007;136:589–96.